Rutaecarpine Attenuates Ovalbumin‐Induced Asthma in Mice by Regulating the NF ‐ κB Pathway
Chemical Biology & Drug Design · 2026-03 · 107 (3)
DOI: 10.1111/cbdd.70275 ↗At a glance
Journal article in Chemical Biology & Drug Design, published online on 2026-03-08. Written by Kongbo Chen and 1 co-authors. Institution: Department of Pediatric Respiratory Medicine, Nanyang Central Hospital (Nanyang Maternal and Child Health Care Hospital), Nanyang, China. Major MEDLINE topics: Quinazolines, NF-kappa B, Asthma, Indole Alkaloids. Cited 1 times so far (Crossref); 53 references.
Abstract (original language)
Pediatric asthma is a common chronic condition with several pathological features, including airway inflammation, remodeling, and oxidative stress. Rutaecarpine (RUT), a bioactive alkaloid, exhibits therapeutic efficacy against various allergic diseases. However, its roles in asthma and the underlying molecular mechanisms remain elusive. In this study, we established an ovalbumin (OVA)‐induced mouse model of asthma. The results showed that compared with the OVA‐challenged group, treatment with RUT (10 and 20 mg/kg) reduced lung tissue inflammatory scores by 37.5% and 50.0%, respectively. Additionally, RUT suppressed the production of interleukin (IL)‐4, IL‐5, and IL‐13, and decreased the counts of total cells, eosinophils, macrophages, neutrophils, and lymphocytes in bronchoalveolar lavage fluid. Regarding airway remodeling, RUT downregulated the mRNA and protein expression of α‐smooth muscle actin and type I collagen. Furthermore, periodic acid‐Schiff staining showed that RUT ameliorated OVA‐induced mucus hypersecretion. RUT treatment also exhibited a protective effect on OVA‐induced oxidative damage in lung tissues. Mechanistically, RUT suppressed OVA‐induced activation of the nuclear factor‐kappa B (NF‐κB) pathway. Collectively, RUT attenuated inflammation, airway remodeling, and oxidative stress in OVA‐induced asthmatic mice by inhibiting the NF‐κB pathway, highlighting its potential as an adjunct therapy for pediatric asthma and providing a theoretical basis for future clinical translation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pediatric Respiratory Medicine, Nanyang Central Hospital (Nanyang Maternal and Child Health Care Hospital), Nanyang, China.
- Department of Pediatrics, Chun'an First People's Hospital, Hangzhou, China.
ORCID profiles: Junwei Chen
Cite
APA
Chen, K., & Chen, J. (2026). Rutaecarpine Attenuates Ovalbumin‐Induced Asthma in Mice by Regulating the NF ‐ κB Pathway. Chemical Biology & Drug Design, 107(3). https://doi.org/10.1111/cbdd.70275
Vancouver
Chen K, Chen J. Rutaecarpine Attenuates Ovalbumin‐Induced Asthma in Mice by Regulating the NF ‐ κB Pathway. Chemical Biology & Drug Design. 2026;107(3). doi:10.1111/cbdd.70275
BibTeX
@article{Chen2026,
author = {Chen, Kongbo and Chen, Junwei},
title = {Rutaecarpine Attenuates Ovalbumin‐Induced Asthma in Mice by Regulating the NF ‐ κB Pathway},
journal = {Chemical Biology & Drug Design},
year = {2026},
volume = {107},
number = {3},
doi = {10.1111/cbdd.70275}
}
EUVIMED